| Symbol | RXST |
|---|---|
| Name | RXSIGHT, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Ophthalmic Goods |
| Address | 100 COLUMBIA, ALISO VIEJO, California, 92656, United States |
| Telephone | +1 949 521-7830 |
| Fax | — |
| — | |
| Website | https://www.rxsight.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001111485 |
| Description | RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. Additional info from NASDAQ: |
The Law Offices of Frank R. Cruz Announces Investigation of RxSight, Inc. (RXST) on Behalf of Investors
Read moreRxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
Read moreNew Form SD - RxSight, Inc. <b>Filed:</b> 2026-05-29 <b>AccNo:</b> 0001193125-26-248890 <b>Size:</b> 1 MB
Read moreNew Form SCHEDULE 13G/A - RxSight, Inc. <b>Filed:</b> 2026-05-13 <b>AccNo:</b> 0001193125-26-220568 <b>Size:</b> 137 KB
Read moreRxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07347379 | Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustabl… | — | Aphakia Cataract | Enrolling_By_Invitation | 2025-11-13 | 2026-09-01 | ClinicalTrials.gov |
| NCT05202808 | RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | Na | Aphakia | Completed | 2021-12-03 | 2024-12-16 | ClinicalTrials.gov |
| NCT04529616 | Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjust… | — | Aphakia | Completed | 2020-05-22 | 2022-10-01 | ClinicalTrials.gov |
| NCT04177771 | A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light … | — | Aphakia | Terminated | 2019-11-15 | 2021-12-20 | ClinicalTrials.gov |
| NCT04005586 | A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Di… | Na | Aphakia | Completed | 2019-07-01 | 2020-03-01 | ClinicalTrials.gov |
| NCT03660865 | Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Ad… | Na | Aphakia | Completed | 2018-08-28 | 2020-04-01 | ClinicalTrials.gov |
| NCT03771352 | Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Del… | Na | Cataract | Completed | 2018-06-19 | 2020-07-01 | ClinicalTrials.gov |
| NCT03895034 | Exploratory Study to Evaluate the Use of the RxSight Light Adjustable Lens (LAL… | — | Aphakia | Completed | 2018-06-14 | 2020-03-01 | ClinicalTrials.gov |
| NCT03729024 | Exploratory Study to Evaluate Uncorrected Distance Vision and Quality of Vision… | Na | Aphakia | Completed | 2018-01-26 | 2020-02-04 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Preclinical | Aphakia | COMPLETED | NCT04529616 |
| RxSight RxLAL | Other | Approved | Cataract | COMPLETED | NCT03771352 |
| Light Delivery Device (LDD) | Device | Approved | Aphakia | COMPLETED | NCT04005586 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Approved | Aphakia | COMPLETED | NCT03729024 |
| Control IOL | Other | Approved | Aphakia | COMPLETED | NCT03660865 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Approved | Aphakia | COMPLETED | NCT03660865 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Preclinical | Aphakia | COMPLETED | NCT03895034 |
| Tecnis ZCB00 or ZTC150 IOL | Other | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| SofPort LI61AO IOL | Other | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Pre-COVID Population | Device | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| Control IOL | Other | Approved | Aphakia | COMPLETED | NCT05202808 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Approved | Aphakia | COMPLETED | NCT05202808 |
| Control IOL | Other | Preclinical | Aphakia Cataract | ENROLLING_BY_INVITATION | NCT07347379 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | Device | Preclinical | Aphakia Cataract | ENROLLING_BY_INVITATION | NCT07347379 |
| Tecnis ZCB00 or ZTC150 IOL | DEVICE | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| SofPort LI61AO IOL | DEVICE | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Pre-COVID Population | DEVICE | Preclinical | Aphakia | TERMINATED | NCT04177771 |
| Light Delivery Device (LDD) | DEVICE | Approved | Aphakia | COMPLETED | NCT04005586 |
| RxSight RxLAL | DEVICE | Approved | Cataract | COMPLETED | NCT03771352 |
| Control IOL | DEVICE | Preclinical | Aphakia Cataract | ENROLLING_BY_INVITATION | NCT07347379 |
| Light Adjustable lens (LAL) and Light Delivery Device (LDD) | DEVICE | Preclinical | Aphakia Cataract | ENROLLING_BY_INVITATION | NCT07347379 |